Listerine meeting rescheduled
This article was originally published in The Rose Sheet
Executive Summary
"Feedback" meeting on Listerine-manufacturer Pfizer's efforts to amend the OTC anticaries final monograph, originally slated for June 18, will be held Aug. 27 at 9201 Corporate Blvd., Rockville, Md., FDA says. At the meeting, Pfizer will seek agency review and confirmation that treatment cells and statistical criteria in its proposed six-month gingivitis study on the .02% sodium fluoride mouthrinse are acceptable and may allow for product's inclusion in the monograph...